Brief: Orchid Pharma gets EIR after FDA inspection at co's API facility in Tamil Nadu
Sept 21 (Reuters) - Orchid Pharma Ltd ORCD.NS
* Says orchid has received establishment inspection
report(EIR) from USFDA
* Says got EIR after fda inspection on co's API facility in
Tamil Nadu
Source text: http://bit.ly/2hirWl6
Further company coverage: ORCD.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Orchid Pharma
See all newsBrief: Orchid Pharma Approves Enabling Resolution To Explore Fund Raising Via Equity Or Other Securities
Brief: Orchid Pharma To Consider And Evaluate Various Options For Raising Funds
Brief: Orchid Pharma June-Quarter Consol Profit 25.8 Million Rupees
India's Orchid Pharma jumps on pact to commercialize Exblifep in Russia
Refile: INDIA STOCKS-Indian shares set to open lower as US-Iran tensions lift oil prices